News about Global Pharma

Orchid Pharma and Cipla to Launch Cefepime-Enmetazobactam in India

Orchid Pharma has launched its new drug, Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.

Global Pharma | 29/06/2024 | By Aishwarya |  1017

Formation Bio Bags USD 372 MM in Series D Funding

Formation Bio has raised USD 372 MM of Series D financing.

Global Pharma | 28/06/2024 | By Aishwarya |  680

CASI Pharmaceuticals Plans to Submit IND Application For CID-103

CASI Pharmaceuticals, Inc. has planned to submit an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for CID-103 for the treatment of antibody-mediated rejection (AMR) in kidney transplant recipients by the end of 2024.

Global Pharma | 28/06/2024 | By Aishwarya |  710

Cellares Signs Deal with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform

Cellares has announced that Kite will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle.

Global Pharma | 28/06/2024 | By Aishwarya |  602

Glenmark and IADVL Raise Awareness Campaign to Support Vitiligo Patients in India

Glenmark Pharmaceuticals Ltd. has joined forces with The Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL), to unveil postcards & Calendars aimed at raising awareness.

Global Pharma | 28/06/2024 | By Aishwarya |  778

Verona Pharma Secures US FDA Approval of Ohtuvayre

Verona Pharma has announced that the US Food and Drug Administration (FDA) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.

Global Pharma | 27/06/2024 | By Aishwarya |  1108

Cipla and Takeda to Commercialize Vonoprazan in India

Cipla has signed a non-exclusive Patent License agreement with Takeda Pharmaceutical company Ltd. for ‘Vonoprazan’ for India Market for treating acid-related illnesses among patients.

Global Pharma | 27/06/2024 | By Aishwarya |  1267

Skyhawk Therapeutics Inaugurates its State-of-the-Art Labs in Switzerland

Skyhawk Therapeutics, Inc. has expanded its facilities with its new state-of-the-art labs in Superlab Suisse, in Basel Switzerland.

Global Pharma | 26/06/2024 | By Aishwarya |  1111

Sen-Jam Pharma Completes Enrollment for Phase 2 URIs or COVID

Sen-Jam Pharmaceutical has completed participant enrollment for the clinical trial of its innovative therapeutic, SJP-002C in partnership with Duke University.

Global Pharma | 25/06/2024 | By Aishwarya |  786

Cypris Therapeutics Bags Over USD 500k in Pre-Seed Funding

Cypris Therapeutics has introduced a breakthrough in synthetic chemistry technology which allows development of novel chemistries for treatment of therapeutically resistant diseases, including brain and pancreatic cancers.

Global Pharma | 25/06/2024 | By Aishwarya |  907